Cargando…

Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness

OBJECTIVE: To compare the cost-effectiveness of undertaking low-dose computed tomography (LDCT) screening for early detection of lung cancer (LC) with different frequencies within the healthcare system of China, and estimate the additional national healthcare expenditure and five-year LC mortality a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Xiaohui, Zhou, Zhen, Luo, Xia, Liu, Qiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558698/ https://www.ncbi.nlm.nih.gov/pubmed/36249202 http://dx.doi.org/10.3389/fpubh.2022.977550

Ejemplares similares

Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer in China
por: Luo, Xia, et al.
Publicado: (2022)

Auxiliary screening COVID-19 by computed tomography
por: Pan, Xiongfeng, et al.
Publicado: (2023)

Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis
por: McLeod, Melissa, et al.
Publicado: (2020)

Integrating a Positron Emission Tomography/Computed Tomography Into the National Health System of Cyprus: Will It Return on Its Investment?
por: Kefallonitou, Dimitra, et al.
Publicado: (2021)

Effects of multimorbidity patterns and socioeconomic status on catastrophic health expenditure of widowed older adults in China
por: Wang, Zhen, et al.
Publicado: (2023)

The Effect of Business Cycles on Health Expenditure: A Story of Income Inequality in China
por: Pu, Xiaohong, et al.
Publicado: (2021)

China national lung cancer screening guideline with low-dose computed tomography (2015 version)
por: Zhou, Qing-hua, et al.
Publicado: (2015)

The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China
por: Zhang, Yuan-jin, et al.
Publicado: (2022)

Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study
por: Qin, Shuxia, et al.
Publicado: (2022)

Households Health Expenditure in Interannual Correlation With Public Health Expenditure in Greece
por: Zikidou, Stavroula, et al.
Publicado: (2020)

Out-of-pocket expenditure and catastrophic costs due to COVID-19 in Indonesia: A rapid online survey
por: Hafidz, Firdaus, et al.
Publicado: (2023)

Catastrophic health expenditure of households with hypertension: a comparative study in China
por: Zhai, Xiaohui, et al.
Publicado: (2023)

Investigation of small lung lesion detection for lung cancer screening in low dose FDG PET imaging by deep neural networks
por: Guo, Haijun, et al.
Publicado: (2022)

A Low-Cost, Low-Skill Model for Efficient Breast Cancer Screening in Low Resource Rural Settings of a Developing Country
por: Khanduri, Sachin, et al.
Publicado: (2017)

Tacrolimus Utilization and Expenditure in Serbia
por: Rancic, Nemanja, et al.
Publicado: (2017)

Development of acceptable quality radiation dose levels for common computed tomography examinations: A focused multicenter study in United Arab Emirates
por: Elshami, Wiam, et al.
Publicado: (2022)

The impact of public health expenditure and gross domestic product per capita on the risk of catastrophic health expenditures for OECD countries
por: Söyük, Selma
Publicado: (2023)

The heterogeneous relationship between public health expenditures and household medical expenditures: evidence from relative poverty households in China
por: Li, Zhenyu, et al.
Publicado: (2023)

Does Economic Policy Uncertainty Matter for Healthcare Expenditure in China? A Spatial Econometric Analysis
por: Bai, Pu, et al.
Publicado: (2021)

The spatial effects of rural toilet retrofitting investment on farmers' medical and health expenditure in China
por: Zheng, Xin, et al.
Publicado: (2023)

Health expenditures, environmental quality, and economic development: State-of-the-art review and findings in the context of COP26
por: Xing, Zhenjiang, et al.
Publicado: (2022)

Cost-Effectiveness of Population Screening Programs for Cardiovascular Diseases and Diabetes in Low- and Middle-Income Countries: A Systematic Review
por: Sharma, Manushi, et al.
Publicado: (2022)

Do Health Expenditures Converge Among ASEAN Countries?
por: Li, Zheng-Zheng, et al.
Publicado: (2021)

The Impacts of Flattening Fiscal Reform on Health Expenditure in China
por: Hao, Jun, et al.
Publicado: (2021)

Analysis of the Household and Health Care System Expenditures in Bulgaria
por: Mitkova, Zornitsa, et al.
Publicado: (2021)

Impact of Catastrophic Health Expenditures on Chinese Household Consumption
por: Wei, Ning, et al.
Publicado: (2021)

Regional catastrophic health expenditure and health inequality in China
por: Wang, Xinyue, et al.
Publicado: (2023)

Minimizing the Risk of Catastrophic Health Expenditure in China: A Multi-Dimensional Analysis of Vulnerable Groups
por: Wang, Jiahui, et al.
Publicado: (2021)

Computed Tomography: Return on Investment and Regional Disparity Factor Analysis
por: Imai, Shinya, et al.
Publicado: (2019)

A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker
por: Toumazis, Iakovos, et al.
Publicado: (2021)

Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China
por: Zhao, Zixuan, et al.
Publicado: (2022)

Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada
por: Thanh, Nguyen Xuan, et al.
Publicado: (2022)

Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations
por: Gou, Hong-Feng, et al.
Publicado: (2016)

Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China
por: Zhang, Weina, et al.
Publicado: (2023)

Long-Term Health Expenditure Changes in Selected Balkan Countries
por: Rancic, Nemanja, et al.
Publicado: (2015)

Estimating the Fiscal Effects of Public Pharmaceutical Expenditure Reduction in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2015)

Healthcare, Insurance, and Medical Expenditure of the Floating Population in Beijing, China
por: Ma, Chenjin, et al.
Publicado: (2020)

Changes in Catastrophic Health Expenditures Depending on Health Policies in Turkey
por: Kockaya, Guvenc, et al.
Publicado: (2021)

Energy Expenditure Estimation of Tabata by Combining Acceleration and Heart Rate
por: Yan, Yiping, et al.
Publicado: (2022)

The Effect of Urbanization on Health Care Expenditure: Evidence From China
por: Shao, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gvfncgto08k1v1e8q9lglhntn5